|Bid||92.83 x 100|
|Ask||103.49 x 100|
|Day's Range||102.05 - 103.09|
|52 Week Range||80.69 - 103.10|
|PE Ratio (TTM)||45.46|
|Earnings Date||Aug 1, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||107.33|
OPKO Health's (OPK) partner VFMCRP gets regulatory nod from Health Canada to market flagship RAYALDEE; benefits patients diagnosed with chronic kidney disease.
On Tuesday, July 17, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Six out of nine sectors ended Tuesday's trading session in bullish territories. Taking into consideration yesterday's market sentiment, WallStEquities.com assessed the following Medical Appliances & Equipment equities this morning: AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX), Masimo Corp. (NASDAQ: MASI), Medtronic PLC (NYSE: MDT), and MiMedx Group Inc. (NASDAQ: MDXG).
Masimo announced today the findings of a recently published study in which researchers at Kocaeli University in Turkey compared the performance of conventional fluid management to goal-directed fluid management using Masimo PVi® in patients undergoing elective colorectal surgery.
Masimo announced today the worldwide release of the Vital Signs Check Application, an integrated patient data collection and workflow application for the Masimo Root® patient monitoring and connectivity platform.
Masimo's (MASI) and STERIS' (STE) strong expected growth rates and impressive price performance make them close contenders in the Medical Instruments space.
Masimo announced today the findings of a study in which researchers evaluated the ability of Masimo ORi™ to detect declining blood oxygenation
Masimo's (MASI) Eve with Rad-97 Pulse CO-Oximeter to be integrated in nine hospitals across UAE for CCHD screening in newborns.
Masimo announced today that the United Arab Emirates Ministry of Health & Prevention is adopting a national screening protocol for critical congenital heart disease for all newborns.
Masimo and Thermomedics, a PositiveID company, announced today the debut and U.S. market release of TIR-1™, a non-contact Bluetooth®-enabled thermometer that integrates seamlessly with the Masimo Root® patient monitoring and connectivity platform.
NEW YORK, June 18, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Opus ...
LONDON, UK / ACCESSWIRE / June 18, 2018/ If you want a free Stock Review on MDXG sign up now at www.wallstequities.com/registration. WallStEquities.com has selected the following stocks for review this morning: Masimo Corp. (NASDAQ: MASI), Medtronic PLC (NYSE: MDT), MiMedx Group Inc. (NASDAQ: MDXG), and Myomo Inc. (NYSE AMER: MYO).
Masimo announced today the findings of an abstract presented at Euroanaesthesia 2018 in which researchers compared Masimo Patient State Index , a processed EEG parameter provided by SedLine® brain function monitoring , to Medtronic Bispectral Index in monitoring the depth of anesthesia of two groups of patients: healthy volunteers undergoing hepatotomy for liver donation and cirrhotic patients undergoing ...
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
Masimo announced today the findings of an abstract presented at Euroanaesthesia 2018 in which researchers compared Masimo noninvasive and continuous hemoglobin (SpHb®
Masimo Corporation (NASDAQ:MASI) outperformed the Healthcare Equipment industry on the basis of its ROE – producing a higher 16.40% relative to the peer average of 11.43% over the past 12Read More...
Masimo (MASI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Women’s Tennis Association and Masimo announced today that the WTA’s Sport Sciences and Medicine team will immediately begin using Masimo MightySat™ as part of their mission to provide comprehensive care for athletes on the women’s professional tennis circuit.
The following five stocks are currently in the midst of uptrends according to VantagePoint, an AI charting platform that uses intermarket analysis to predict future price action 1-3 days in advance. The blue line is a predicted moving average that forecasts a what a stock's 6-day moving average will be in 72 hours. Masimo Corporation (NASDAQ: MASI) had a predictive moving average crossover to the upside in early-April indicating a bullish trend.